Order results by:
| Issue | Title | |
| Vol 17, No 2 (2025) | 12-year experience of incobotulinumtoxinA use in neurological practice | Abstract similar documents |
| N. V. Kireeva, E. G. Bukreeva, D. S. Kireev | ||
| "... , a widely used in pediatric and adult practice with proven efficacy and a favorable safety profile ..." | ||
| Vol 15, No 3 (2023) | Clinical effectiveness and safety of prolonged release form of alimemazine in patients with generalized anxiety disorder | Abstract similar documents |
| Ju. E. Azimova, Yu. P. Sivolap, K. A. Ishchenko | ||
| "... treatment of generalized anxiety disorder (GAD). Objective: to investigate the efficacy and safety ..." | ||
| Vol 15, No 3 (2023) | Safety and tolerability of repetitive transcranial magnetic stimulation: an analysis of over 1200 sessions | Abstract similar documents |
| I. S. Bakulin, A. Kh. Zabirova, A. G. Poydasheva, D. Yu. Lagoda, N. A. Suponeva, M. A. Piradov | ||
| "... , therefore, the issues of its safety and tolerability are especially important. Currently, serious adverse ..." | ||
| Vol 12, No 5 (2020) | The polymorphic variants DRD2 rs1800497 and ABCB1 3435C>T are associated with antipsychotic safety parameters in adolescents with an acute psychotic episode: the results of a pilot study | Abstract PDF (Eng) similar documents |
| D. V. Ivashchenko, S. Z. Khoang, M. Kh. Tazagulova, B. V. Makhmudova, N. I. Buromskaya, P. V. Shimanov, R. V. Deitch, I. V. Dorina, M. I. Nastovich, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... for the safety of antipsychotics in adults. Patients and methods. The study enrolled 36 adolescents (58.3% male ..." | ||
| Vol 12, No 2 (2020) | Etoricoxib can be used for chronic nonspecific back pain: a new indication of the well-known drug | Abstract similar documents |
| A. E. Karateev | ||
| "... is determined by the efficacy, ease of use, and safety profile of a particular drug. Etoricoxib is one ..." | ||
| Vol 17, No 1 (2025) | A new representative of the group of non-steroidal anti-inflammatory drugs in the therapeutic arsenal of a Russian doctor: pelubiprofen | Abstract similar documents |
| A. E. Karateev | ||
| "... pharmaceutical market can be considered ideal in terms of efficacy/safety ratio. This determines the feasibility ..." | ||
| Vol 12, No 3 (2020) | A Russian retrospective multicenter open-label observational study based on medical documentation on the use of perampanel in everyday clinical practice | Abstract PDF (Eng) similar documents |
| P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, D. V. Dmitrenko, I. G. Rudakova, T. V. Danilova, V. A. Kalinin, O. V. Grebenyuk, A. P. Gertsen, Ya. S. Zhuravlev, A. Yu. Karas, E. N. Paramonova, I. V. Ponomareva, O. I. Miguskina, N. A. Sobyanina, D. V. Sukhova, Yu. V. Salomatin, M. L. Ertakhova, T. M. Goguadze, A. P. Shamray | ||
| "... a predictable safety profile. ..." | ||
| Vol 14, No 5 (2022) | Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups | Abstract similar documents |
| E. A. Ushkalova, S. K. Zyryanov, O. I. Butranova | ||
| "... multiple pharmacological effects. In order to study the safety of Mexidol in comparison with placebo ..." | ||
| Vol 12, No 6 (2020) | Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes | Abstract similar documents |
| D. V. Ivashchenko, A. S. Osipov, E. V. Nazarova, M. A. Ovchinnikova, N. I. Buromskaya, V. V. Smirnov, P. V. Shimanov, R. V. Deitch, T. A. Fainshtein, E. N. Shagovenko, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... of CYP3A and CYP2D6 isoenzyme activity parameters with the efficacy and safety of antipsychotics ..." | ||
| Vol 15, No 4 (2023) | Evaluation of pharmacokinetic parameters, safety and tolerability of single and multiple doses of Vespireit®: results of phase I clinical trial. | Abstract similar documents |
| O. D. Ostroumova, M. L. Maksimov, M. V. Zamergrad, V. A. Parfenov, E. K. Zaharova, A. L. Vladykin, A. A. Globenko, A. V. Kapashin, K. A. Ishchenko | ||
| "... Objective: to evaluate the pharmacokinetic parameters, safety and tolerability of Vespireit® (INN ..." | ||
| Vol 13, No 6 (2021) | Multicenter, randomized, double-blind study of the efficacy and safety of prolonged release tolperisone hydrochloride 450 mg (Mydocalm® Long, once daily) and tolperisone hydrochloride 150 mg (three times daily) for acute non-specific lower back pain | Abstract similar documents |
| V. A. Parfenov, E. I. Bogdanov, V. B. Laskov, N. S. Makarov, N. V. Pisova, E. A. Salina, Zh. Yu. Chefranova, L. V. Chichanovskaya | ||
| "... and safety of the new dosage form of PRTH 450 (Mydocalm® Long, once a day) in comparison with TH 150 ..." | ||
| 1 - 11 of 11 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
